Prescription drug · ANDA
memantine hydrochloride NDC 68180-249
Memantine hydrochloride 28 mg/1 · Capsule, Extended release · Oral · Lupin Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68180-249-06 | 68180024906 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68180-249-06)Marketed from Feb 20, 2018 | |
| 68180-249-09 | 68180024909 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68180-249-09)Marketed from Feb 20, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- memantine hydrochloride
- Generic name (nonproprietary)
- memantine hydrochloride
- Active ingredients
- Memantine hydrochloride — 28 mg/1
- Dosage form
- Capsule, Extended release
- Route
- Oral
- Labeler
- Lupin Pharmaceuticals, Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 206028
- Marketing start
- Listing expires
- Other FDA classes
- NMDA Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 68180-249_2eba035e-38ce-479d-8dc8-0bfdd2bffbcfSPL ID 2eba035e-38ce-479d-8dc8-0bfdd2bffbcfSPL set ID 24290655-47f3-4042-a977-a832c5161d2cRxCUI 996594, 996603, 996609, 996615UNII JY0WD0UA60UPC 0368180247067, 0368180249061, 0368180246060
- Pharmacologic class
- N-methyl-D-aspartate Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468180024906followed by a unit qualifier and the quantityPackage 68180-0249-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Memantine hydrochloride extended-release capsules are a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer's type. ( 1 ) Memantine hydrochloride extended-release capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer's type.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 206028
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| memantine hydrochloride | Memantine hydrochloride 7 mg/1 | Capsule, Extended releaseOral | Major Pharmaceuticals | 0904-6734 |
| memantine hydrochloride | Memantine hydrochloride 28 mg/1 | Capsule, Extended releaseOral | Major Pharmaceuticals | 0904-6735 |
| memantine hydrochloride | Memantine hydrochloride 7 mg/1 | Capsule, Extended releaseOral | Lupin Pharmaceuticals, Inc. | 68180-246 |
| memantine hydrochloride | Memantine hydrochloride 14 mg/1 | Capsule, Extended releaseOral | Lupin Pharmaceuticals, Inc. | 68180-247 |
| memantine hydrochloride | Memantine hydrochloride 21 mg/1 | Capsule, Extended releaseOral | Lupin Pharmaceuticals, Inc. | 68180-248 |